Evidence map›Paper›PMID 32850365›Full record

ArticleFrontiers in oncology2020

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities.

Avis Harden, Dristhi Ragoonanan, Daryl Anildes-Gubman, David McCall, Kathleen Faltus, Sarah Featherston, Basirat Shoberu, Jerelyn R Moffet, Demetrios Petropoulos, Sajad J Khazal and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Clinical simulation in health education: a systematic review.Investigacion y educacion en enfermeria · 2023
    Pooled it
  2. Understanding Physician Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Avis HardenDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Dristhi RagoonananDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Daryl Anildes-GubmanTeaching, Interprofessional and Simulation Education Center, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
David McCallDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Kathleen FaltusDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Sarah FeatherstonDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Basirat ShoberuDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Jerelyn R MoffetDivision of Blood and Marrow Transplant, Department of Pediatrics, Duke Children's Hospital, Duke University, Durham, NC, United States.
Demetrios PetropoulosDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Sajad J KhazalDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Shehla RazviDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Kris M MahadeoDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Priti TewariDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
The University of Texas MD Anderson Cancer Center · USDuke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19

Indexed as

cytokine release syndrome (CRS)educationimmune effector cell-associated neurotoxicity (ICANS)inter-professionalsimulation-based

Identifiers

PMID32850365
PMCPMC7419673
OpenAlexW3047319626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.